1.lack of legislation prohibiting counterfeiting of drugs
2.Weak penal sanctions
3.Weak or absent national drug regulatory authorities
4.Weak enforcement of drug laws
5.Shortage and/or erratic supply of drugs
6.Lack of control of drugs for export
7.Trade involving several intermediaries and free trade zones
8.Corruption and conflict of interest